Skip to main content
Caplight Logo









gMendel

gMendel

Private
CopenhagenHealthcare & Life Scienceshttps://g-mendel.com/

Last Round

Seed

Apr 15, 2026

Total Funding Raised

$4.38M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

gMendel is a Danish medical technology company that provides an AI-powered software platform for affordable and scalable mass screening of genetic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

genetic testinggenomic analysisrare disease diagnosisclinical decision supportprecision medicineAI diagnosticsin vitro diagnosticsIVDnewborn screeninggenomic softwarevariant callingbioinformatics automationhealth-techmedtechdiagnostic SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

gMendel Comparables

Compare gMendel with similar companies based on industry and business-model similarity.

gMendel comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SeqOne
78%
Genomenon Inc.
77%
Labcorp
76%

gMendel Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 15, 2026
GrantNov 1, 2023
GrantMar 2, 2023

Key People

Founding team and executive leadership

Chris Kyriakidis

CEO & Co-Founder

Founding Team

gMendel Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    $1.4M raised in Seed funding.

  • Mar 2, 2023

    $550K grant received from Eurostars SME programme.

gMendel Filings

Explore SEC and related filing metadata, where available.

gMendel filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about gMendel's valuation, stock price, and market status.

Is gMendel a public or private company?

gMendel is a private company.

What is the current stock price of gMendel?

gMendel is a private company with no public stock price. No recent secondary market data is available.

How much is gMendel worth (valuation)?

Valuation information for gMendel is not publicly available.

Can I buy gMendel stock?

gMendel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was gMendel's last funding round?

gMendel's most recent funding round was Seed on April 15, 2026.

Who are the main investors in gMendel?

Key investors in gMendel include Metavallon.

Will gMendel IPO soon?

No public IPO plans have been announced for gMendel.

How can I track gMendel secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor gMendel's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCopenhagen
Employee Range8
Year Founded2020
Last FundingApr 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?